The Supra Incubation Center, devoted to integrating resources for biotechnology, will begin operations Nov. 1 under the Executive Yuan, according to SIC Director Soo Whai-jen.
To boost Taiwan’s burgeoning biotech industry, Soo said, the center will focus on identifying profitable new drugs and equipment, formulating complete industry value chains for each case and bringing products to market in the shortest time possible.
Soo said he will conduct a comprehensive review of biotech research projects presented by local academics to identify potentially profitable drugs.
To read the full, original article click on this link: Original Article
